B. D. Aaaaaaaaa, M. D. Jjjjjjj, C. D. Pppppppp, C. Jjjjjjjjoooooooo, J. Cc et al., Increasing Echinocandin Resistance in Candida glabrata : Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations, Clinical Infectious Diseases, pp.56-1724, 2013.

T. M. Aaaaaaaa, M. C. Ccc, A. G. Cccccc, K. A. Dddd, G. S. Hhhh et al., Amphotericin forms an extramembranous and fungicidal sterol sponge, Nature Chemical Biology, pp.10-400, 2014.

E. Aaaaaa, M. Ttttttt, V. Lllllllllbbb, and R. Hhhhhhhhh, Nouvelles formes lipidiques de l'amphotéricine B. Revue de la littérature, La revue de médecine interne, pp.141-150

A. and R. Du, Comité des médicaments à usage humain (CHMP) relatives à l'utilisation du métoclopramide, du kétoconazole par voie orale et des incrétinomimétiques, 2013.

M. C. Aaaaaaaa, E. Dddddd, R. H. Jjjjjj, H. K. Jjjjjjjj, P. Kkkkkkkkkk et al., Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia : data from a nationwide fungaemia surveillance programme, Clinical Microbiology and Infection, pp.19-343, 2013.

M. C. Aaaaaaaa, M. A. Pp, and . Ggggg, Caspofungin Etest Susceptibility Testing of Candida Species : Risk of Misclassiication of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints, Antimicrobial Agents and Chemotherapy, pp.56-3965, 2012.

M. C. Aaaaaaaa, S. Sssss, A. Hhhh, L. Nnnnnnn, S. D. Nnnnnnn et al., Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia ?, Journal of Clinical Microbiology, pp.49-3300, 2011.

C. J. Aaaaaa, M. Jjjjjjj, A. S. Bb, S. Bbbbbbb, E. Gggggggggg et al., Candida infective endocarditis : an observational cohort study with a focus on therapy, Antimicrobial Agents and Chemotherapy, pp.59-2365, 2015.

T. A. , L. Lllll, and M. P. , PCR Diagnosis of Invasive Candidiasis : Systematic Review and Meta-Analysis, Journal of Clinical Microbiology, vol.49, pp.665-670, 2011.

S. V. Bbbbbbb, S. P. , and D. S. Pppppp, Assessing Resistance to the Echinocandin Antifungal Drug Caspofungin in Candida albicans by Prooling Mutations in FKS1, Antimicrobial Agents and Chemotherapy, vol.50, pp.2058-2063, 2006.

M. Bbbbbbbb, M. Mmmmmmmmm, A. Ccccccccccc, S. Ccccccc, J. Gggggmmmmmmm et al., A research agenda on the management of intra-abdominal candidiasis : results from a consensus of multinational experts, Intensive Care Medicine, pp.39-2092, 2013.

M. Bbbbbbbb, E. Rrrrr, F. Aaaaaaa, M. Mmmmmmm, C. Sssss et al., A multicenter multinational study of abdominal candidiasis : epidemiology, outcomes and predictors of mortality, Intensive Care Medicine, pp.41-1601, 2015.

R. Bbbbaaa, G. Ggggggeeeeee, R. E. Lllll, S. Ggggggg, K. Llllll et al., Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance, Journal of Infectious Diseases, pp.204-626, 2011.

G. Bbbbb, Y. Ll, L. Cccc, Q. Y. , X. M. Nnn et al., New insights into the echinocandins and other fungal non-ribosomal peptides and peptaibiotics, Natural Product Reports, pp.31-1348, 2014.

D. Bbb, O. Llllllllll, F. Dddddd, B. Cccccccc, and D. Ccc, Mycoses invasives en France métropolitaine, PMSI 2001-2010 : incidence, létalité et tendances, Bull Epidémiol Hebd, pp.12-13, 2013.

D. Bbb, O. Llllllllll, Y. Ll-ssss, J. Nnnnnn, B. Cccccccc et al., Populationbased analysis of invasive fungal infections, Emerging Infectious Diseases, pp.20-1149, 2001.

F. C. Bbbbbbb, A. S. Mmmm, E. Kk, E. Ffffffffff, A. H. Ssss et al., Changes in Cell Wall Synthesis and Ultrastructure during Paradoxical Growth EEect of Caspofungin on Four Diierent Candida Species, Antimicrobial Agents and Chemotherapy, pp.55-302, 2011.

E. Bbbbbbbbb, O. Llllllllll, K. Bbbbbbbbssssss, M. Dddddddoooooooo, F. Dddddd et al., Prior Caspofungin Exposure in Patients with Hematological Malignancies Is a Risk Factor for Subsequent Fungemia Due to Decreased Susceptibility in Candida spp. : a Case-Control Study, Antimicrobial Agents and Chemotherapy, pp.55-5358, 2011.

B. Bbb, Les endophtalmies endogènes d'origine fongique, Journal Français d'Ophtalmologie, vol.34, pp.40-45, 2011.

N. Bbbbbbbbb, C. Ll, S. Bbbb, Y. Bbbbbb, D. Kkkkkkk et al., Assessment of caspofungin susceptibility of Candida glabrata, European Journal of Clinical Microbiology & Infectious Diseases, vol.33, pp.1247-1252, 2014.

S. M. Bb-s and . Ffff, The structure and synthesis of the fungal cell wall, BioEssays, pp.28-799, 2006.

S. and B. B. Hhhh, Two unlike cousins : Candida albicans and C. glabrata infection strategies, Cellular Microbiology, vol.15, pp.701-708, 2013.

G. Cc, F. Pppppppp, C. Ccccccc, M. Gggggg, I. Aaaaaaa et al., Candida Colonization Index in Patients Admitted to an ICU, International Journal of Molecular Sciences, pp.12-7038, 2011.

E. D. Ccccccc, A. Vvvvv, A. R. Ffffff, P. P. , D. S. Pppppp et al., Use of Matrix- Assisted Laser Desorption Ionization?Time of Flight Mass Spectrometry for Caspofungin Susceptibility Testing of Candida and Aspergillus Species, Journal of Clinical Microbiology, pp.50-2479, 2012.

C. Ccccc, A. C. Nnnnnnn, C. L. Oooooooo, S. Rrrrr, and R. Pppppppp, Performance of MALDI-TOF MS platforms for fungal identiication, Mycoses, 2016.

M. Cccc, S. A. Mmmmmm, P. R. Rrrrrrrr, and M. A. Pp, Antifungal susceptibility patterns of a global collection of fungal isolates : results of the SENTRY Antifungal Surveillance Program, Diagnostic Microbiology and Infectious Disease, pp.85-200, 2013.

M. Cccc, L. N. , D. J. Ddddddd, S. A. Mmmmmm, R. N. Jjjjj et al., PP, Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains, Antimicrobial Agents and Chemotherapy, pp.54-2655, 2010.

D. Cccccccc, Classiication des champignons d'intérêt médical, Encycl Méd Chir, 2008.

G. Cccccccc, R. E. Lllll, N. Aaaaaa, and D. P. , Paradoxical EEect of Echinocandins across Candida Species In Vitro : Evidence for Echinocandin-Speciic and Candida Species-Related Diierences, Antimicrobial Agents and Chemotherapy, pp.51-2257, 2007.

F. Ccccccc, M. Bbbbbbbbbbbb, and P. Sssss, In vitro susceptibility proole of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents, Journal De Mycologie Médicale, vol.24, pp.303-307, 2014.

C. J. Cccccc, H. Hh, S. Ccccc, H. Ddddddddd, and M. H. Nnnnnn, Characterizing the EEects of Caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata Isolates by Simultaneous Time-Kill and Postantifungal- EEect Experiments, Antimicrobial Agents and Chemotherapy, pp.50-2569, 2006.

C. J. Cccccc-m, . Nnnnnn, and . Finding-the, Missing 50% " of Invasive Candidiasis : How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care, Clinical Infectious Diseases, pp.56-1284, 2013.

L. and C. Y. Jjjjjjjjsssssss, Clinical and microbiological diagnosis of oral candidiasis, Journal of Clinical and Experimental Dentistry, vol.5, pp.279-286, 2013.

M. Cccccceeeeeeee, A. Gggggglllll, A. Aaaaaaaaaiiiiiiii, L. Bbbbbbbmmmmmmmm, I. Ccccc et al., Comparison of the Vitek 2 Antifungal Susceptibility System with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest Techniques for In Vitro Detection of Antifungal Resistance in Yeast Isolates, Journal of Clinical Microbiology, pp.48-1782, 2010.

R. E. Cccccc, A. D. Bbbbb, and M. R. Kkkk, Flucytosine kinetics in subjects with normal and impaired renal function, Clinical Pharmacology & Therapeutics, vol.24, pp.333-342, 1978.

M. Dddddddoooooooo, O. Mmmmm, T. Cccc, A. M. Gggggg, and F. Dddddd, Development of Echinocandin Resistance in Clavispora lusitaniae during Caspofungin Treatment ?, Journal of Clinical Microbiology, pp.49-2304, 2011.

B. P. Dddddd, C. G. Ttttttt, J. D. Bbbbbb, S. W. , and W. H. Cccccc, Recurrent candida prosthetic endocarditis over fteen years managed with medical therapy and four valvular surgeries : a case report and review of literature, Journal of Cardiothoracic Surgery, p.10, 2015.

D. J. Ddddddd, S. A. Mmmmmm, A. B. Bbbbbbbbbbb, S. L. Ccccccc, G. V. Ddddd et al., Epidemiology of Candidemia : 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study, Journal of Clinical Microbiology, pp.40-1298, 2002.

D. J. Ddddddd, S. A. Mmmmmm, R. J. Hhhhhh, R. P. Wwwwww, and M. A. , PP, An outbreak of Candida parapsilosis prosthetic valve endocarditis, Diagnostic Microbiology and Infectious Disease, pp.29-147, 1997.

C. F. Ooooooo, G. Ddd, A. Ssss, C. Bb, A. Mmmm et al., Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo, The Journal of Experimental Medicine, pp.191-1661, 2000.

C. Dddddd, S. Ggggggg, F. Llllllllll, C. Jjjjjjjjoooooooo, J. Aaaa et al., Set of Classical PCRs for Detection of Mutations in Candida glabrata FKS Genes Linked with Echinocandin Resistance, Journal of Clinical Microbiology, pp.52-2609, 2014.

C. Dddddddd, A. M. Rrrrrr, F. L. Hhhhhhh, and C. Arrrrrr, Première étude multicentrique de la consommation des antifongiques en établissements de santé, Médecine et Maladies Infectieuses, pp.44-73, 2014.

P. and E. D. Pppppp, Candida colonization index and subsequent infection in critically ill surgical patients : 20 years later, Intensive Care Medicine, vol.40, pp.1429-1448, 2014.

S. Eeekkkkccc, K. Ddddddddd, and T. Nnnn, A two-step cloning-free PCR-based method for the deletion of genes in the opportunistic pathogenic yeast Candida lusitaniae, Yeast, pp.28-321, 2011.

T. Eeee, L. Mmmmmmm, V. Tttt, and I. Ppppp, Echinocandins : production and applications, Applied Microbiology and Biotechnology, vol.97, pp.3267-3284, 2013.

N. Eeeeeee, U. H. Mmmmmmmmm, and R. Rr, Cloning-Free PCR-Based Allele Replacement Methods, Genome Research, vol.7, pp.1174-1183, 1997.

L. P. Eeeee-n and . Gg, Interactions of fungal pathogens with phagocytes, Nature Reviews Microbiology, vol.14, pp.163-176, 2016.

G. Eeeeeee, D. D. Ddpppppp, and P. L. Cccccc, Comparison of echinocandin antifungals, Therapeutics and Clinical Risk Management, vol.3, pp.71-97, 2007.

A. Eeeeeeeeiiiiiii, M. C. Aaaaaaaa, M. A. Pp, L. X. Bbbbbbbbb, B. Bbbb et al., Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods : Should the Clinical Laboratory Be Testing This Agent ?, Antimicrobial Agents and Chemotherapy, pp.57-5836, 2013.

A. Eeeeeeeeiiiiiii, E. Cccc, J. Ppppp, and E. Mmmmmmmmmmmmmm, Comparison of Anidulafungin MICs Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Method (M27-A3 Document) and Etest for Candida Species Isolates, Antimicrobial Agents and Chemotherapy, pp.54-1347, 2010.

E. , A. , and C. Spp, Rationale for the EUCAST clinical breakpoints, version 2.0, tech. report, 2013.

E. , M. , and C. Spp, Rationale for the EUCAST clinical breakpoints, 2013.

F. Ffffffffffsss, M. Ll, J. Ccccccc, E. Mm, D. Ssss et al., In vitro antifungal susceptibility of Candida glabrata to caspofungin and the presence of FKS mutations correlate with treatment response in an immunocompromised murine model of invasive infection, Antimicrobial Agents and Chemotherapy, pp.58-3646, 2014.

G. N. Fffffff, E. Wwwwww, and J. K. Jjjjjjj, Increasing incidence of Candida parapsilosis candidemia with caspofungin usage, Journal of Infection, vol.56, pp.126-129, 2008.

E. Ffffff, V. Ccccc, A. J. Ssssss, O. Pppppp, J. Cccccc et al., P, Optimization of the URA-blaster disruption system in Candida guilliermondii : eecient gene targeting using the URA3 marker, Journal of Microbiological Methods, pp.91-117, 2012.

P. Ffffffff, C. Ssssssss, D. Mm, A. Vvvvv, B. Lllll et al., Antifungal use innuences Candida species distribution and susceptibility in the intensive care unit, The Journal of Antimicrobial Chemotherapy, pp.66-2880, 2011.

F. Ffffffff, F. Ccccccccclllllll, J. V. , and T. Nnnn, Development of an integrative transformation system for the opportunistic pathogenic yeast Candida lusitaniae using URA3 as a selection marker, Yeast, vol.21, pp.95-106, 2004.

J. J. Gg-n and . Ggggg, Candidemia in the in-patient setting : treatment options and economics, Expert Opinion on Pharmacotherapy, vol.8, pp.1643-1650, 2007.

M. N. Gggggggggg, D. P. , N. V. Ssssss, B. Mmmmm, E. Aaaaaaaaa et al., Analysis of 207 Pediatric and Adult Cases, Clinical Infectious Diseases, pp.55-1338, 1970.

G. Ggggggeeeeee, S. K. Kk, S. P. , T. D. Eeeeee, and D. S. Pppppp, A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility, Antimicrobial Agents and Chemotherapy, pp.52-2305, 2008.

G. Ggggggeeeeee, S. Lll, S. P. , J. D. Cccccc, and D. S. Pppppp, EEect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-?-d-Glucan Synthase : Implication for the Existing Susceptibility Breakpoint, Antimicrobial Agents and Chemotherapy, pp.53-3690, 2009.

G. Ggggggeeeeee, S. P. , and D. S. Pppppp, Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans : Implications for Interpretive Breakpoints, Antimicrobial Agents and Chemotherapy, vol.53, pp.112-122, 2009.

K. W. Ggggg, M. Rrrr, M. P. , D. E. Mmmmm, K. J. Sss et al., Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia : A Multi-Institutional Study, Clinical Infectious Diseases, pp.43-68, 2006.

C. Ggggg, F. Bb, N. Ssss, M. E. Bbbbbbbb, E. Ddddd et al., Next-generation sequencing ooers new insights into the resistance of Candida spp. to echinocandins and azoles, The Journal of Antimicrobial Chemotherapy, pp.70-2556, 2015.

D. G. Gggggg, G. A. Bbbbbbb, K. C. Aaaaaaa, J. Zz, M. A. Aaaaaa et al., One-step assembly in yeast of 25 overlapping DNA fragments to form a complete synthetic Mycoplasma genitalium genome, Proceedings of the National Academy of Sciences, pp.105-20404, 2008.

S. Ggggaaaaaa, N. Jj, E. Eeeee, and G. , Postantifungal EEect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis, PLOS ONE, vol.10, p.132730, 2015.

D. G. Ggg, N. Y. , P. Iiii, C. Bb, A. Oooop et al., Candida Associated Bloodstream Infections in Pediatric Hematology Patients : A Single Center Experience, Mediterranean Journal of Hematology and Infectious Diseases, vol.8, 2016.

N. A. Gg, F. L. Vvvvvvvv, A. J. Bbb, and M. G. Nnnnn, Candida albicans morphogenesis and host defence : discriminating invasion from colonization, Nature reviews. Microbiology, vol.10, pp.112-122, 2011.

J. Gggggg, Global trends in the distribution of Candida species causing candidemia, Clinical Microbiology and Infection, vol.20, issue.6, pp.5-10, 2014.

Y. E. Hh, K. R. Pppp, E. J. Jjj, S. W. Kkk, S. I. Jjjj et al., Impact of First-Line Antifungal Agents on the Outcomes and Costs of Candidemia, Antimicrobial Agents and Chemotherapy, pp.56-3950, 2012.

M. Hhhhh, J. F. Ss, and K. A. Mmmm, Emergence of a Candida krusei Isolate with Reduced Susceptibility to Caspofungin during Therapy, Antimicrobial Agents and Chemotherapy, vol.50, pp.2522-2524, 2006.

K. R. Hhhhhh, K. K. Cccccc, T. D. Eeeeee, and S. K. Kk, Sphingolipids mediate diierential echinocandin susceptibility in Candida albicans and Aspergillus nidulans, Antimicrobial Agents and Chemotherapy, pp.4667-4681, 2015.

K. R. Hhhhhh, S. K. Kk, M. Cccc, M. A. Pp, and T. D. Eeeeee, Candida glabrata Mutants Demonstrating Paradoxical Reduced Caspofungin Susceptibility but Increased Micafungin Susceptibility, Antimicrobial Agents and Chemotherapy, pp.55-3947, 2011.

K. R. Hhhhhh, S. K. Kk, S. Rrr, T. D. Eeeeee, and C. In, glabrata : sphingolipids modulate echinocandin-Fks interaction, Molecular microbiology, pp.303-313, 2012.

K. R. Hhhhhh, Y. Zzz, W. B. Ppppp, S. R. Llllllll, J. D. Sssss et al., Prevalent mutator genotype identiied in fungal pathogen Candida glabrata promotes multi-drug resistance, Nature Communications, vol.7, p.11128, 2016.

E. D. Hhhhhhh, M. K. Zzz, M. Mmmmmmmm, M. E. Rrrr, A. G. Ffffffff et al., Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients : a matched case-control study, Critical Care, pp.15-198, 2011.

N. Hhhh, N. Mmmmmmmm, T. Kkkkkk, K. Uuuuu, and K. Iiiiiiii, Protocol : a simple gel-free method for SNP genotyping using allele-speciic primers in rice and other plant species, Plant Methods, vol.6, p.12, 2010.

D. Hhhhhhhh, P. A. , J. Ggggggg, I. Gggg, G. Bbbbbbbb et al., Endophtalmie endogène à Candida secondaire à l'utilisation de la buprénorphine par voie intraveineuse, Journal Français d'Ophtalmologie, pp.31-180, 2008.

C. F. Hhhhhhhh, E. D. Cccccccc, G. M. Hhhhhhhh, and P. D. Rrrrrr, Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents, Antimicrobial Agents and Chemotherapy, vol.54, pp.1655-1664, 2010.

W. W. Hhhh, L. T. , D. W. Ddddddd, and M. J. Aaaaaaaa, Molecular Mechanisms of Primary Resistance to Flucytosine in Candida albicans, Antimicrobial Agents and Chemotherapy, pp.48-4377, 2004.

S. Iiiiii, L. Cccc, A. P. , S. Jj, I. Mmmmm et al., Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidemia, Clinical Microbiology and Infection

C. J. Iiiiii-p and . Ssssssssssss, Microcolony Imaging of Aspergillus fumigatus Treated with Echinocandins Reveals Both Fungistatic and Fungicidal Activities, PLOS ONE, vol.7, p.35478, 2012.

S. Iiiiiiii, A. Hhhh, S. Nnnnnn, A. Bbb, J. P. Ll et al., Homologous Subunits of 1,3-Beta-Glucan Synthase Are Important for Spore Wall Assembly in Saccharomyces cerevisiae, Eukaryotic Cell, vol.6, pp.143-156, 2007.

D. E. Kkkk, F. Nnnnnnn, A. Mmmmmmmmmmmmm, P. I. Rrr, and M. E. Ffff,-?-d-glucan, Assay for the Diagnosis of Invasive Fungal Infections : A Meta-analysis, Clinical Infectious Diseases, pp.52-750, 2011.

N. Kkkkkkkkk, J. Kkkkkk, L. Mmmmmm, C. M. Hhh, C. Sssss et al., Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis : Relationship of MIC to Treatment Outcome, Antimicrobial Agents and Chemotherapy, pp.49-3616, 2005.

S. K. Kk, A. Aaaaaaaaaiiiiiiii, K. R. Hhhhhh, M. E. Jjjjjjj, D. S. Pppppp et al., Fks1 and Fks2 Are Functionally Redundant but Diierentially Regulated in Candida glabrata : Implications for Echinocandin Resistance, Antimicrobial Agents and Chemotherapy, pp.56-6304, 2012.

S. K. Kk-t and . Eeeeee, Role for Fks1 in the Intrinsic Echinocandin Resistance of Fusarium solani as Evidenced by Hybrid Expression in Saccharomyces cerevisiae, Antimicrobial Agents and Chemotherapy, vol.53, pp.1772-1778, 2009.

J. Kkkk, R. Rr, M. Mmcccc, and K. Kk, Exposure to caspofungin activates Cap and Hog pathways in Candida albicans, Medical Mycology, pp.47-697, 2009.

U. Kkk, D. Ssssss, B. W. , E. Sssssssss, J. Bbbb et al., Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria, Mycoses, pp.59-312, 2016.

K. Kkkk, T. Bbbb, U. Nn, K. Wwww, A. Lllll et al., HHHH, I. W, New monomeric and dimeric uridinyl derivatives as inhibitors of chitin synthase, Bioorganic Chemistry, pp.61-74, 2015.

C. K. , J. W. Ffff, and T. Bbbbbbbb, The Yeasts : A Taxonomic Study, 2011.

M. Ll, M. Ttttttttt, M. Ssssssss, K. K. , C. Mmmm et al., Positions and Numbers of FKS Mutations in Candida albicans Selectively Innuence In Vitro and In Vivo Susceptibilities to Echinocandin Treatment, Antimicrobial Agents and Chemotherapy, pp.58-3626, 2014.

C. Llll, S. Rrrrrssss, P. Sss, B. Aaaaaaaaa, J. Nnnnnsssss et al., A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization, Critical Care Medicine, pp.34-730, 2006.

D. E. Lllll, Cell Wall Integrity Signaling in Saccharomyces cerevisiae, Microbiology and Molecular Biology Reviews, vol.69, pp.262-291, 2005.

D. E. Lllll, Regulation of Cell Wall Biogenesis in Saccharomyces cerevisiae : The Cell Wall Integrity Signaling Pathway, Genetics, pp.189-1145, 2011.

J. Lll, S. Hh, M. Sss, S. Lll, Y. Lll et al., An improved allele-speciic PCR primer design method for SNP marker analysis and its application, Plant Methods, vol.8, p.34, 2012.

O. Llllllllll, M. Dddddddoooooooo, K. Ssssss, A. Ffff, S. Bbbb et al., Recent exposure to caspofungin or uconazole innuences the epidemiology of candidemia : a prospective multicenter study involving 2,441 patients, Antimicrobial Agents and Chemotherapy, pp.55-532, 2011.

O. Llllllllll, C. Rrrr, K. Ssssss, Y. Mmmmm, L. Dddddddnn et al., Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, Intensive Care Medicine, pp.40-1303, 2002.

P. M. Ccc, S. G. Tttt, and M. V. Ddddd, Chitin Synthase Inhibitors as Antifungal Agents, Mini-Reviews in Medicinal Chemistry, pp.222-236, 2013.

H. Mm, S. K. , P. J. Ssss, and D. Bb, Plasmid construction by homologous recombination in yeast, Gene, pp.58-201, 1987.

P. Mmmmm, S. C. Wwwww, J. Mmee, and R. H. Ssssssss, Micro-homology mediated PCR targeting in Saccharomyces cerevisiae, Nucleic Acids Research, vol.23, pp.2799-2800, 1995.

M. C. Mmmmmmmmmjjjjjjj, P. Mmmmm, J. Gggggg, M. V. , R. Aaaaaa et al., Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia, Medical Mycology, pp.52-270, 2014.

E. Mm, L. Bb, S. Ttttttttt, J. Mmddddd, M. Cccc et al., Candidemia surveillance in Iowa : emergence of echinocandin resistance, Diagnostic Microbiology and Infectious Disease, pp.79-205, 2014.

P. Mmmmm, N. Mmmmm, W. Bb, M. Sssssssss, J. A. Cccccc et al., Diierential expression and function of two homologous subunits of yeast 1,3-beta-D-glucan synthase, Molecular and Cellular Biology, pp.15-5671, 1995.

A. S. Mmmm, A. L. Ccccccc, and B. A. , AAAAAAAASSS, Paradoxical Growth EEect of Caspofungin Observed on Bioolms and Planktonic Cells of Five Diierent Candida Species, Antimicrobial Agents and Chemotherapy, pp.51-3081, 2007.

S. A. Mmmmmm, R. N. Jjjjj, and T. R. Ffffffff, International Surveillance of Candida spp. and Aspergillus spp, Report from the SENTRY Antimicrobial Surveillance Program, pp.44-1782, 2003.

M. Mmmmmmmm, T. Cccccccc, M. Sssssssssss, D. P. , C. V. et al., The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis : recommendations from the, Third European Conference on Infections in Leukemia, pp.14-222, 2010.

T. Mmm, M. Aasssssss, Y. T. , H. T. , S. B. Iiiii et al., Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis, Journal of Bacteriology, pp.179-4096, 1997.

M. Mmmmmmm, V. J. Ffffff, and M. H. , Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained : a Potential Risk Factor for Hospital Mortality, Antimicrobial Agents and Chemotherapy, pp.49-3640, 2005.

M. G. Nnnnn, L. A. Jjjjjjj, J. W. Mmmm, B. J. , and F. L. Vvvvvvvv, Immune defence against Candida fungal infections, Nature Reviews Immunology, vol.15, pp.630-642, 2015.

K. Nnnnn, B. C. Mmmm, A. Hhhhh, K. Hh, T. Uuuu et al., Clinically signiicant micafungin resistance in Candida albicans involves modiication of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity, Journal of Antimicrobial Chemotherapy, pp.65-842, 2010.

H. Oooo, M. Aaa, M. Aaaaammmmmmmm, A. Hhhh, H. Qqqq et al., Multiple Functional Domains of the Yeast l,3-?-Glucan Synthase Subunit Fks1p Revealed by Quantitative Phenotypic Analysis of Temperature-Sensitive Mutants, Genetics, pp.184-1013, 2010.

H. Oooo, S. Oooooo, C. Rrrrrrr, J. B. , and Y. Ooo, Distinct roles of cell wall biogenesis in yeast morphogenesis as revealed by multivariate analysis of high-dimensional morphometric data, Molecular Biology of the Cell, vol.25, pp.222-233, 2014.

L. Oooooooozzzzzzzz, A. Ccccccc, J. N. Gggggggg, F. C. Oooo, and J. H. Rrr, An insight into the antifungal pipeline : selected new molecules and beyond, Nature Reviews Drug Discovery, vol.9, pp.719-727, 2010.

J. A. , J. M. Ppppppp, A. T. , A. Mmmmm, F. B. Cccc et al., Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs : data from the EUROBACT study, Critical Care, p.20, 2016.

S. A. , J. B. Nnnnnnn, N. Mmmmm, G. Ccccccc, N. Rrrrr et al., Calcineurin-dependent growth of an FK506-and CsA-hypersensitive mutant of Saccharomyces cerevisiae, Journal of General Microbiology, pp.139-2973, 1993.

A. P. , M. T. Bbbbbbbb, F. T. , C. Ccccc, and J. Ddddddccccc, Émergence de candidémies à Candida parapsilosis à l'hôpital Cochin. Caractérisation des isolats et recherche de facteurs de risque, Pathologie Biologie, pp.59-103, 2011.

M. A. Pp, D. R. Aaaaa, D. J. Ddddddd, D. L. Hhhh, A. C. Rrrrrr et al., Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients : Data from the Prospective Antifungal Therapy (PATH) Registry, PLoS ONE, pp.9-101510, 2004.

M. A. Pp, M. Cccc, S. R. Llllllll, A. M. Aaaaaaa, S. A. Mmmmmm et al., Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata, Journal of Clinical Microbiology, pp.50-1199, 2012.

M. A. Pp, M. Cccc, S. A. Mmmmmm, and R. N. Jjjjj, In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents : data from the SENTRY antifungal surveillance program, Mycoses, pp.58-209, 2010.

M. A. Pp, M. Cccc, S. A. Mmmmmm, P. R. Rrrrrrrr, and R. N. Jjjjj, Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 Systemically active antifungal agents when tested against Candida spp, Diagnostic Microbiology and Infectious Disease, pp.79-198, 2014.

M. A. Pp-d and . Ddddddd, Epidemiology of Invasive Candidiasis : a Persistent Public Health Problem, Clinical Microbiology Reviews, vol.20, pp.133-163, 2007.

M. A. Pp, D. J. Ddddddd, D. Aaaaa, M. C. Aaaaaaaa, S. D. Bbb et al., Clinical breakpoints for the echinocandins and Candida revisited : Integration of molecular, clinical, and microbiological data to arrive at species-speciic interpretive criteria, Drug Resistance Updates, pp.14-164, 2011.

M. A. Pp, D. J. Ddddddd, R. N. Jjjjj, H. S. Sssss, A. C. Fffff et al., International surveillance of bloodstream infections due to Candida species : frequency of occurrence and in vitro susceptibilities to uconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program, Journal of Clinical Microbiology, pp.39-3254, 2001.

M. A. Pp, D. J. Ddddddd, M. Mmmmmm, C. Kkkkkkk, P. Eeeeeeee et al., an Opportunistic Fungal Pathogen with Decreased Susceptibility to Fluconazole : Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, Journal of Clinical Microbiology, pp.44-3551, 2006.

M. A. Pp, S. A. Mmmmmm, D. J. Ddddddd, R. N. Jjjjj, and M. Cccc, Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria, Journal of Clinical Microbiology, pp.52-108, 2014.

M. A. Pp, S. A. Mmmmmm, L. N. , R. N. Jjjjj, and M. Cccc, Echinocandin and Triazole Antifungal Susceptibility Prooles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011 : Application of New CLSI Clinical Breakpoints and Epidemiological Cutoo Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance, Journal of Clinical Microbiology, pp.51-2571, 2013.

M. A. Pp, G. J. Mmmm, S. A. Mmmmmm, R. N. Jjjjj, and M. Cccc, Candida Bloodstream Infections : Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, Antimicrobial Agents and Chemotherapy, pp.55-561, 2008.

C. D. Pppp, C. B. Bbbbbb, R. J. , and S. R. Llllllll, Development of a Luminex-Based Multiplex Assay for Detection of Mutations Conferring Resistance to Echinocandins in Candida glabrata, Journal of Clinical Microbiology, pp.52-790, 2014.

C. A. Ppppppp, J. Eeeeeeee, R. Bbbbbbb, and M. Bbbb, Ergosterol gene expression in wild-type and ergosterol-deecient mutants of Candida albicans, Medical Mycology, pp.42-385, 2004.

D. Pppppp, M. Mmmmm, P. M. Sssss, E. Fffff, and R. , A, Candida colonization and subsequent infections in critically ill surgical patients, Annals of Surgery, vol.220, pp.751-758, 1994.

E. G. Ppp, J. Llllll, M. Kkkkk, E. S. Mmbbbbb, G. R. Nnnnn et al., Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients, Intensive Care Medicine, pp.35-2141, 2009.

E. P. , O. Lllllllllll, V. J. Aaaaaaa, I. K. , J. Lllll et al., Secular trend in candidemia and the use of uconazole in Finland, BMC Infectious Diseases, p.10, 2004.

B. P. , G. Dd-p, M. Tttttttttt, R. T. , M. Ppppppp et al., Early diagnosis of candidemia in intensive care unit patients with sepsis : a prospective comparison of (1?3)-?-D-glucan assay, Candida score, and colonization index, Critical Care, pp.15-249, 2011.

M. W. , M. L. , V. Ddddddd, D. W. , and R. H. Dddd, Overview of treatment options for invasive fungal infections, Medical Mycology, pp.1-20, 2011.

S. J. Pppppp-m and . Llllll, Characterization of Virulence-Related Phenotypes in Candida Species of the CUG Clade, Eukaryotic Cell, vol.14, pp.931-940, 2015.

M. Pppppaaaaaaa, B. P. , J. Gggggmmmmmmm, O. Zzzz, J. M. et al., Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections : a population-based surveillance in Spain, Clinical Microbiology and Infection, pp.20-245, 2014.

B. Rrrrrrrr, A. Dddddddddd, and O. Llllllllll, New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis, Mycoses, pp.55-74, 2012.

F. G. Rrrr, S. Cccccccc, C. Fffffffff, S. Rr, L. Fffff et al., The EEect on Mortality of Fluconazole or Echinocandins Treatment in Candidemia in Internal Medicine Wards, PLOS ONE, pp.10-0125149, 2015.

J. M. Rrrrr, K. R. Mmmm, A. T. Nnnnnnn, and P. D. Rrrrrr, Isavuconazole : Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent, Pharmacotherapy : The Journal of Human Pharmacology and Drug Therapy, pp.35-1037, 2015.

L. D. Ssss, L. Oooooooozzzzzzzz, K. A. Mmmm, J. H. Rrr, S. H. Ccccc et al., Time for a New, Clinical Infectious Diseases, vol.37, pp.415-425, 2003.

T. Ssss, K. T. , K. Aaaaa, S. Y. , H. Mmmmmm et al., Breakthrough Invasive Candida glabrata in Patients on Micafungin : a Novel FKS Gene Conversion Correlated with Sequential Elevation of MIC, Journal of Clinical Microbiology, pp.52-2709, 2014.

A. Ssssss, R. Lll, A. Bbbbbbbbbb, and A. Mmmm, Comparison of microdilution method and E-test procedure in susceptibility testing of caspofungin against Candida non-albicans species, The New Microbiologica, pp.31-257, 2008.

R. S. Sssssss, N. Rrrrrrr, and L. E. Cc, Regulatory Circuitry Governing Fungal Development, Drug Resistance, and Disease, Microbiology and Molecular Biology Reviews, pp.75-213, 2011.

X. Y. Sss, Y. P. , Y. Zzzzz, W. Ll, J. D. et al., Molecular identiication and antifungal susceptibility of 186 Candida isolates from vulvovaginal candidiasis in southern China, Journal of Medical Microbiology, pp.64-390, 2015.

R. K. Sssssss, M. H. Nnnnnn, C. Dd, E. Ppppp, S. Ccccc et al., Paradoxical eeect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum, Antimicrobial Agents and Chemotherapy, pp.55-2641, 2011.

R. K. Sssssss, M. H. Nnnnnn, E. Ppppp, and C. J. Cccccc, Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin Resistance, Antimicrobial Agents and Chemotherapy, vol.58, pp.7601-7605, 2014.

R. K. Sssssss, M. H. Nnnnnn, E. G. Ppppp, and C. J. Cccccc, Five-Minute Exposure to Caspofungin Results in Prolonged Postantifungal EEects and Eliminates the Paradoxical Growth of Candida albicans, Antimicrobial Agents and Chemotherapy, pp.55-3598, 2011.

R. K. Sssssss, M. H. Nnnnnn, E. G. Ppppp, R. Cccccc, E. Dddddddd et al., Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection, Antimicrobial Agents and Chemotherapy, pp.59-7465, 2015.

R. K. Sssssss, M. H. Nnnnnn, E. G. Ppppp, A. L. , S. Ccccc et al., The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata, Antimicrobial Agents and Chemotherapy, pp.56-4862, 2012.

R. K. Sssssss, M. H. Nnnnnn, E. G. Ppppp, C. L. Uuuuuu, and C. J. Cccccc, Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for Identifying FKS Mutant Candida glabrata Strains and Echinocandin Resistance, Antimicrobial Agents and Chemotherapy, pp.57-6361, 2013.

R. K. Sssssss, M. H. Nnnnnn, C. L. Uuuuuu, E. G. Ppppp, and C. J. Cccccc, Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure, Antimicrobial Agents and Chemotherapy, vol.57, pp.3528-3535, 2013.

N. V. Ssssss, R. E. Lllll, J. T. , R. Hh, K. V. Rrrrr et al., Candidemia in patients with hematologic malignancies in the era of new antifungal agents, Cancer, pp.115-4745, 2001.

R. P. Sssss, A. Bbb, L. H. Bbbb, W. J. Rrrr, and P. P. Mmmmmmmmm, Post-antifungal eeects and time-kill studies of anidulafungin , caspofungin, and micafungin against Candida glabrata and Candida parapsilosis, Diagnostic Microbiology and Infectious Disease, pp.71-131, 2011.

Y. B. Ssss, M. K. Sss, G. Y. Hh, and H. Kkk, Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis, Annals of Dermatology, vol.27, pp.715-720, 2015.

D. J. Ss, R. A. Hhh, and P. A. Hhhhhh, Atlas d'ophtalmologie clinique, 1996.

J. F. Ss and . Sssssssss, URA3 as a selectable marker for disruption and virulence assessment of Candida albicans genes, Trends in Microbiology, vol.11, pp.69-73, 2003.

P. Sssssss, N. Gg, and J. Bbbbbb, The distinct morphogenic states of Candida albicans, Trends in Microbiology, vol.12, pp.317-324, 2004.

P. E. Sssssss, Growth of Candida albicans hyphae, Nature Reviews Microbiology, vol.9, pp.737-748, 2011.

G. R. Tttttttt, N. P. , J. S. Lllll, and T. F. , Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection, Antimicrobial Agents and Chemotherapy, pp.52-3783, 2008.

J. H. , P. L. Gggggggg, W. Hhhhhh-w, L. A. Tttttttt, and G. F. Hhhhhh, A counterselection for the tryptophan pathway in yeast : 5--uoroanthranilic acid resistance, Yeast, pp.16-553, 2000.

J. Tttttttt, G. Kkkkkkkkk, and G. Kkkkk, Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-oo values, Clinical Microbiology and Infection, vol.12, pp.418-425, 2006.

S. V. , A. A. Ccccccccc, M. M. Ffffff, L. H. Hhhhhhhh, W. Sssssssss et al., Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections : Data From a Large Multisite Population-Based Candidemia Surveillance Program, Open Forum Infectious Diseases, p.163, 2008.

A. E. Vvvvvvvt and . Bbbbbb, Macrophages in resistance to candidiasis, Microbiology and Molecular Biology Reviews, pp.61-170, 1997.

E. and V. R. Bbbbb, A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia, European Journal of Clinical Microbiology & Infectious Diseases : OOcial Publication of the European Society of Clinical Microbiology, pp.27-1071, 2008.

A. Vvvvvv, H. J. Ggggggggg, and J. Ddddddd, Flucytosine : a review of its pharmacology, clinical indications, pharmacokinetics , toxicity and drug interactions, Journal of Antimicrobial Chemotherapy, pp.46-171, 2000.

L. A. , N. A. Gg, and C. A. Mmmmm, Fungal echinocandin resistance, Fungal Genetics and Biology, pp.47-117, 2010.

L. A. , C. A. Mmmmm, I. Bbbbbb, M. D. Llllllll, A. Mmkkkkkk et al., Stimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins, PLoS Pathog, vol.4, p.1000040, 2008.

T. J. , R. W. Fffffff, C. Aaaa, J. Hhhhhhh, C. Ssss et al., Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia, New England Journal of Medicine, pp.340-764, 1999.

A. W. , J. Cc, S. Hh, Z. Zzz, M. W. et al., Anterior and pan-endophthalmitis caused by Candida albicans and Aspergillus fumigatus : report of two cases, Mycopathologia, pp.176-451, 2013.

S. J. , Y. L. Ccccc, and Y. L. Cccc, Calcineurin signaling : lessons from Candida species, FEMS yeast research, vol.15, p.16, 2015.